192 related articles for article (PubMed ID: 12503213)
1. Advances in the staging of renal cell carcinoma.
Leung AC; Ghavamian R
Expert Rev Anticancer Ther; 2002 Dec; 2(6):673-80. PubMed ID: 12503213
[TBL] [Abstract][Full Text] [Related]
2. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
3. Nephron-sparing surgery in renal cell carcinoma: did we sacrifice too many kidneys in the past?
Fornara P
Eur Urol; 2007 Jun; 51(6):1475-6. PubMed ID: 17287074
[No Abstract] [Full Text] [Related]
4. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
5. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
7. Impact of resection margin status after nephron-sparing surgery for renal cell carcinoma.
Berdjis N; Hakenberg OW; Zastrow S; Oehlschläger S; Novotny V; Wirth MP
BJU Int; 2006 Jun; 97(6):1208-10. PubMed ID: 16686712
[TBL] [Abstract][Full Text] [Related]
8. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
Srivastava A; Mandhani A; Kapoor R; Jain M; Dubey D; Srivastava A; Raghavendra M; Kumar A
Indian J Cancer; 2004; 41(3):99-103. PubMed ID: 15472406
[TBL] [Abstract][Full Text] [Related]
9. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
10. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
[TBL] [Abstract][Full Text] [Related]
11. Renal masses: urologic management.
Ornstein DK; Arcangeli CG; Andriole GL
Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):1-12. PubMed ID: 8995121
[TBL] [Abstract][Full Text] [Related]
12. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract][Full Text] [Related]
13. Treatment trends for stage I renal cell carcinoma.
Cooperberg MR; Mallin K; Kane CJ; Carroll PR
J Urol; 2011 Aug; 186(2):394-9. PubMed ID: 21679982
[TBL] [Abstract][Full Text] [Related]
14. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
15. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
17. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
[TBL] [Abstract][Full Text] [Related]
18. Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery.
Porpiglia F; Fiori C; Terrone C; Bollito E; Fontana D; Scarpa RM
J Urol; 2005 Apr; 173(4):1098-101. PubMed ID: 15758709
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
20. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
Lam JS; Breda A; Belldegrun AS; Figlin RA
J Clin Oncol; 2006 Dec; 24(35):5565-75. PubMed ID: 17158542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
